Advances in the clinical translation of nanotechnology.

about

Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ.Lessons learned from protein aggregation: toward technological and biomedical applications.

P2860

Q42658857-3096E062-C410-4EA7-980B-84840E544854 Q46173279-91A29AF2-E4AD-4C5D-8836-46925E832396

P2860

Advances in the clinical translation of nanotechnology.

Item

http://www.wikidata.org/entity/Q39130471

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Advances in the clinical translation of nanotechnology.

@en

Advances in the clinical translation of nanotechnology.

@nl

type

Item

label

Advances in the clinical translation of nanotechnology.

@en

Advances in the clinical translation of nanotechnology.

@nl

prefLabel

Advances in the clinical translation of nanotechnology.

@en

Advances in the clinical translation of nanotechnology.

@nl

P1476

Advances in the clinical translation of nanotechnology.

@en

P2093

David A Scheinberg

http://www.w3.org/2001/XMLSchema#string

Evan P Stater

http://www.w3.org/2001/XMLSchema#string

Jan Grimm

http://www.w3.org/2001/XMLSchema#string

Michael R McDevitt

http://www.w3.org/2001/XMLSchema#string

Michelle Bradbury

http://www.w3.org/2001/XMLSchema#string

P2860

The promises and pitfalls of RNA-interference-based therapeutics

A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements

Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

DNA Nanotechnology for Cancer Therapy

Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery.

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Current prospects for RNA interference-based therapies

Nanoparticle therapeutics: an emerging treatment modality for cancer

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

P304

66-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.COPBIO.2017.01.002

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel A. Heller

P577

2017-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28187340

http://www.w3.org/2001/XMLSchema#string

P921

nanotechnology

P932

5544552

http://www.w3.org/2001/XMLSchema#string

Advances in the clinical translation of nanotechnology.

about

P2860

P2860

Advances in the clinical translation of nanotechnology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932